Literature DB >> 12964110

Cultivation of Tropheryma whipplei from cerebrospinal fluid.

Matthias Maiwald1, Axel von Herbay, David N Fredricks, Cleber C Ouverney, Jon C Kosek, David A Relman.   

Abstract

Whipple disease (WD) is a systemic disorder caused by the bacterium Tropheryma whipplei. Since the recognition of a bacterial etiology in 1961, many attempts have been made to cultivate this bacterium in vitro. It was eventually isolated, in 2000, from an infected heart valve, in coculture with human fibroblasts. Here we report the isolation of 2 new strains of T. whipplei from cerebrospinal fluid (CSF) of 2 patients with intestinal WD but no neurological signs or symptoms. One culture-positive specimen was obtained before treatment; the other was obtained 12 months after discontinuation of therapy, at a time of intestinal remission. In both cases, 15 passages of the cultures were completed over 17 months. Bacterial growth was measured by quantitative polymerase chain reaction, which suggested a generation time of 4 days. Staining with YO-PRO nucleic-acid dye showed characteristic rod-shaped bacteria arranged in chains. Fluorescent in situ hybridization with a T. whipplei-specific oligonucleotide probe, a broad-range bacterial probe, and a nonspecific nucleic-acid stain indicated that all visible bacteria were T. whipplei. Scanning electron microscopy and transmission electron microscopy showed both intracellular and extracellular bacteria. This first isolation of T. whipplei from CSF provides clear evidence of viable bacteria in the central nervous system in individuals with WD, even after prolonged antibiotic therapy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12964110     DOI: 10.1086/378073

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  9 in total

1.  MR imaging of central nervous system Whipple disease: a 15-year review.

Authors:  D F Black; A J Aksamit; J M Morris
Journal:  AJNR Am J Neuroradiol       Date:  2010-04-15       Impact factor: 3.825

2.  Use of shell-vial cell culture assay for isolation of bacteria from clinical specimens: 13 years of experience.

Authors:  Frédérique Gouriet; Florence Fenollar; Jean-Yves Patrice; Michel Drancourt; Didier Raoult
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

Review 3.  The dormant blood microbiome in chronic, inflammatory diseases.

Authors:  Marnie Potgieter; Janette Bester; Douglas B Kell; Etheresia Pretorius
Journal:  FEMS Microbiol Rev       Date:  2015-05-03       Impact factor: 16.408

4.  Production of monoclonal antibodies to Tropheryma whipplei and identification of recognized epitopes by two-dimensional electrophoresis and mass spectrometry.

Authors:  Yuefei Yu; Malgorzata Kowalczewska; Philippe Decloquement; Claude Nappez; Bernard La Scola
Journal:  J Clin Microbiol       Date:  2006-09-20       Impact factor: 5.948

Review 5.  Invasion of the central nervous system by intracellular bacteria.

Authors:  Douglas A Drevets; Pieter J M Leenen; Ronald A Greenfield
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

6.  Tropheryma whipplei in children with gastroenteritis.

Authors:  Didier Raoult; Florence Fenollar; Jean Marc Rolain; Philippe Minodier; Emmanuelle Bosdure; Wenjun Li; Jean Marc Garnier; Herve Richet
Journal:  Emerg Infect Dis       Date:  2010-05       Impact factor: 6.883

7.  Tropheryma whipplei Infection of an acellular porcine heart valve bioprosthesis in a patient who did not have intestinal Whipple's disease.

Authors:  Jens Dreier; Florian Szabados; Axel von Herbay; Thilo Kröger; Knut Kleesiek
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

8.  Central Nervous System Whipple Disease Presenting as Hypersomnolence.

Authors:  Marcela A de Oliveira Santana; Saira Butt; Mehdi Nassiri
Journal:  Cureus       Date:  2022-03-28

9.  Capsule Endoscopy in the Diagnosis, Disease Mapping, and Monitoring of Treatment Response in Gastrointestinal Whipple's Disease.

Authors:  Emily Davenport; Grigorios Mitsopoulos; Nina Stafford; Arvind Sangwaiya; Sohail Shariq
Journal:  ACG Case Rep J       Date:  2022-09-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.